273 related articles for article (PubMed ID: 24927467)
1. Clinical evidence of the relationship between aspirin and breast cancer risk (review).
Jacobo-Herrera NJ; Pérez-Plasencia C; Camacho-Zavala E; González GF; Urrutia EL; García-Castillo V; Zentella-Dehesa A
Oncol Rep; 2014 Aug; 32(2):451. PubMed ID: 24927467
[TBL] [Abstract][Full Text] [Related]
2. Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.
Johnson TW; Anderson KE; Lazovich D; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1586-91. PubMed ID: 12496048
[TBL] [Abstract][Full Text] [Related]
3. Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer.
Rahme E; Ghosn J; Dasgupta K; Rajan R; Hudson M
BMC Cancer; 2005 Dec; 5():159. PubMed ID: 16343343
[TBL] [Abstract][Full Text] [Related]
4. Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005.
Mangiapane S; Blettner M; Schlattmann P
Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):115-24. PubMed ID: 17955496
[TBL] [Abstract][Full Text] [Related]
5. Aspirin and NSAIDs: effects in breast and ovarian cancers.
Crew KD; Neugut AI
Curr Opin Obstet Gynecol; 2006 Feb; 18(1):71-5. PubMed ID: 16493264
[TBL] [Abstract][Full Text] [Related]
6. NSAIDs and breast cancer: a possible prevention and treatment strategy.
Agrawal A; Fentiman IS
Int J Clin Pract; 2008 Mar; 62(3):444-9. PubMed ID: 18194278
[TBL] [Abstract][Full Text] [Related]
7. Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort.
Jacobs EJ; Thun MJ; Connell CJ; Rodriguez C; Henley SJ; Feigelson HS; Patel AV; Flanders WD; Calle EE
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):261-4. PubMed ID: 15668504
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors enhance the effect of cyclooxygenase inhibitors on breast cancer: a nationwide case-control study.
Lee HH; Tsan YT; Ho WC; Lin MH; Lee CH; Tseng CD; Guo YL; Wang JD; Chen PC;
J Hypertens; 2012 Dec; 30(12):2432-9. PubMed ID: 23027181
[TBL] [Abstract][Full Text] [Related]
9. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.
Harris RE; Chlebowski RT; Jackson RD; Frid DJ; Ascenseo JL; Anderson G; Loar A; Rodabough RJ; White E; McTiernan A;
Cancer Res; 2003 Sep; 63(18):6096-101. PubMed ID: 14522941
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk.
Shen J; Gammon MD; Terry MB; Teitelbaum SL; Neugut AI; Santella RM
Breast Cancer Res; 2006; 8(6):R71. PubMed ID: 17181859
[TBL] [Abstract][Full Text] [Related]
12. Aspirin and NSAIDs for breast cancer chemoprevention.
Yiannakopoulou ECh
Eur J Cancer Prev; 2015 Sep; 24(5):416-21. PubMed ID: 25380191
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.
Takkouche B; Regueira-Méndez C; Etminan M
J Natl Cancer Inst; 2008 Oct; 100(20):1439-47. PubMed ID: 18840819
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study.
Gierach GL; Lacey JV; Schatzkin A; Leitzmann MF; Richesson D; Hollenbeck AR; Brinton LA
Breast Cancer Res; 2008; 10(2):R38. PubMed ID: 18447943
[TBL] [Abstract][Full Text] [Related]
15. Association of regular aspirin use and breast cancer risk.
Swede H; Mirand AL; Menezes RJ; Moysich KB
Oncology; 2005; 68(1):40-7. PubMed ID: 15802928
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study.
Friis S; Thomassen L; Sørensen HT; Tjønneland A; Overvad K; Cronin-Fenton DP; Vogel U; McLaughlin JK; Blot WJ; Olsen JH
Eur J Cancer Prev; 2008 Apr; 17(2):88-96. PubMed ID: 18287865
[TBL] [Abstract][Full Text] [Related]
17. Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk: A dose-response meta-analysis.
Huang XZ; Chen Y; Wu J; Zhang X; Wu CC; Zhang CY; Sun SS; Chen WJ
Oncotarget; 2017 Jan; 8(3):4781-4795. PubMed ID: 27902474
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer.
Harris RE; Kasbari S; Farrar WB
Oncol Rep; 1999; 6(1):71-3. PubMed ID: 9864404
[TBL] [Abstract][Full Text] [Related]
19. Non-steroidal anti-inflammatory drugs and selective apoptotic anti-neoplastic drugs in the prevention of colorectal cancer: the role of super aspirins.
Strul H; Arber N
Isr Med Assoc J; 2000 Sep; 2(9):695-702. PubMed ID: 11062772
[TBL] [Abstract][Full Text] [Related]
20. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
